Population pharmacokinetics of mefloquine in patients with acute falciparum malaria

Clinical Pharmacology and Therapeutics

Volumn 66, Issue 5, 1999, Pages 472-484

  Simpson, Julie A ^b   Price, Ric ^b   Ter Kuile, Feiko ^b   Teja Isavatharm, Paktiya ^b   Nosten, François ^b   Chongsuphajaisiddhi, Tan ^b   Looareesuwan, Sornchai ^b   Aarons, Leon ^b   White, Nicholas J ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; MEFLOQUINE;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; CHILD; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PRIORITY JOURNAL;

EID: 0032749075     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(99)70010-X     Document Type: Article

References (18)

1. 1. Palmer KJ, Holliday SM, Brogden RN. Mefloquine: a review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1993;45:430-75.
2. 2. Nosten F, ter Kuile F, Chongsuphajaisiddhi T, Luxemburger C, Webster HK, Edstein M, et al. Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet 1991;337:1140-3.
3. 3. ter Kuile FO, Nosten F, Thieren M, Luxemburger C, Edstein MD, Chongsuphajaisiddhi T, et al. High dose mefloquine in the treatment of multidrug resistant falciparum malaria. J Infect Dis 1992;166:1393-400.
4. 4. Price RN, Nosten F, Luxemburger C, Kham A, Brockman A, Chongsuphajaisiddhi T, et al. Artesunate versus artemether in combination with mefloquine for the treatment of multidrug resistant falciparum malaria. Trans R Soc Trop Med Hyg 1995;89:523-7.
5. 5. Nosten F, Luxemburger C, ter Kuile FO, Woodrow C, Eh JP, Chongsuphajaisiddhi T, et al. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate mefloquine combination. J Infect Dis 1994; 170:971-7.
6. 6. World Health Organization. Control of tropical diseases: severe and complicated malaria. Trans R Soc Trop Med Hyg 1990;84(suppl 2):1-65.
7. 7. Price RN, Nosten F, Luxemburger C, van Vugt M, Phaipun L, Chongsuphajaisiddhi T, et al. Artesunate/ mefloquine treatment of multi-drug resistant falciparum malaria. Trans R Soc Trop Med Hyg 1997,91:574-7.
8. 8. Edstein MD, Lika ID, Chongsuphajaisiddhi T, Sabcharoen A, Webster HK. Quantitation of Fansimef components (mefloquine + sulfadoxine + pyrimethamine) in human plasma by two high performance liquid Chromatographic methods. Ther Drug Monit 1991;13:146-51.
9. 9. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York: Marcel Dekker; 1982.
10. 10. ter Kuile FO, Dolan G, Nosten F, Edstein MD, Luxemburger C, Phaipun L, et al. Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria. Lancet 1993;341:1044-9.
11. 11. Price RN, Simpson JA, Teja-Isavatharm P, Than MM, Luxemburger C, Heppner DG, et al. Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria. Antimicrob Agents Chemother 1999;43:341-6.
12. 12. Nosten F, ter Kuile F, Chongsuphajaisiddhi T, Na Bangchang K, Karbwang J, White NJ. Mefloquine pharmacokinetics and resistance in children with acute falciparum malaria. Br J Clin Pharmacol 1991;31:556-9.
13. 13. Lindstrom MJ, Bates DM. Nonlinear mixed effects models for repeated measures data. Biometrics 1990;46: 673-87.
14. 14. ter Kuile FO, Teja-Isavatharm P, Edstein MD, Keeratithakul D, Dolan G, Nosten F, et al. Comparison of capillary whole blood, venous whole blood, and plasma concentrations of mefloquine, halofantrine, and desbutylhalofantrine measured by high-performance liquid chromatography. Am J Trop Med Hyg 1994;51:778-4.
15. 15. White NJ. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother 1997;41:1413-22.
16. 16. ter Kuile FO, Nosten F, Luxemburger C, Kyle D, Teja-Isavatharm P, Phaipun L, et al. Mefloquine treatment of acute falciparum malaria: a prospective study of nonserious adverse effects in 3673 patients. Bull World Health Organ 1995;73:631-42.
17. 17. ter Kuile FO, Luxemburger C, Nosten F, Phaipun L, Chongsuphajaisiddhi T, White NJ. Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg 1995;89:660-4.
18. 18. White NJ, van Vugt M, Ezzet F. Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine. Clin Pharmacokinet 1999;37:105-25.